<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">PLoS Negl Trop Dis</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosntds</journal-id>
      <journal-title-group>
        <journal-title>PLoS Neglected Tropical Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1935-2727</issn>
      <issn pub-type="epub">1935-2735</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22860147</article-id>
      <article-id pub-id-type="pmc">3409118</article-id>
      <article-id pub-id-type="publisher-id">PNTD-D-11-01187</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pntd.0001747</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Symposium</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Infectious Diseases</subject>
            <subj-group>
              <subject>Bacterial Diseases</subject>
              <subj-group>
                <subject>Buruli Ulcer</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Neglected Tropical Diseases</subject>
              <subj-group>
                <subject>Buruli Ulcer</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Spontaneous Clearance of a Secondary Buruli Ulcer Lesion Emerging Ten Months after Completion of Chemotherapy&#x2014;A Case Report from Togo</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Beissner</surname>
            <given-names>Marcus</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Piten</surname>
            <given-names>Ebekalisai</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maman</surname>
            <given-names>Issaka</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Symank</surname>
            <given-names>Dominik</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jansson</surname>
            <given-names>Moritz</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nitschke</surname>
            <given-names>J&#xF6;rg</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Amekuse</surname>
            <given-names>Komi</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kobara</surname>
            <given-names>Basil</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">
            <sup>6</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wiedemann</surname>
            <given-names>Franz</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hoffmann</surname>
            <given-names>Harald</given-names>
          </name>
          <xref ref-type="aff" rid="aff7">
            <sup>7</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Diefenhardt</surname>
            <given-names>Adolf</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Badziklou</surname>
            <given-names>Kossi</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Banla Kere</surname>
            <given-names>Abiba</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>L&#xF6;scher</surname>
            <given-names>Thomas</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bretzel</surname>
            <given-names>Gisela</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <addr-line>Department of Infectious Diseases and Tropical Medicine (DITM), University Hospital, Ludwig-Maximilians University, Munich, Germany</addr-line>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <addr-line>Centre Hospitalier R&#xE9;gional Maritime (CHR Maritime), Ts&#xE9;vi&#xE9;, Togo</addr-line>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <addr-line>Institut National d'Hygi&#xE8;ne (INH), Lom&#xE9;, Togo</addr-line>
      </aff>
      <aff id="aff4">
        <label>4</label>
        <addr-line>German Leprosy and Tuberculosis Relief Association (DAHW), W&#xFC;rzburg, Germany</addr-line>
      </aff>
      <aff id="aff5">
        <label>5</label>
        <addr-line>German Leprosy and Tuberculosis Relief Association (DAHW), Togo office, Lom&#xE9;, Togo</addr-line>
      </aff>
      <aff id="aff6">
        <label>6</label>
        <addr-line>Programme National de Lutte contre L'Ulc&#xE8;re de Buruli &#x2013; L&#xE8;pre et Pian (PNLUB-LP), Lom&#xE9;, Togo</addr-line>
      </aff>
      <aff id="aff7">
        <label>7</label>
        <addr-line>Institute of Microbiology and Laboratory Medicine, Pneumological Teaching Hospital of the University of Munich, Gauting, Germany</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Phillips</surname>
            <given-names>Richard O.</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">
        <addr-line>Kwame Nkrumah University of Science and Technology (KNUST) School of Medical Sciences, Ghana</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email>beissner@lrz.uni-muenchen.de</email></corresp>
        <fn fn-type="conflict">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <month>7</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>7</month>
        <year>2012</year>
      </pub-date>
      <volume>6</volume>
      <issue>7</issue>
      <elocation-id>e1747</elocation-id>
      <permissions>
        <copyright-year>2012</copyright-year>
        <copyright-holder>Beissner et al</copyright-holder>
        <license>
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <funding-group>
        <funding-statement>The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement N&#xB0; 241500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder's website is accessible via <ext-link ext-link-type="uri" xlink:href="http://ec.europa.eu/research/health/infectious-diseases/neglected-diseases/projects/012_en.html">http://ec.europa.eu/research/health/infectious-diseases/neglected-diseases/projects/012_en.html</ext-link>.</funding-statement>
      </funding-group>
      <counts>
        <page-count count="7"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Presentation of Case</title>
      <p>An eight-year-old boy from Togo presented with a nodule of 30 mm in diameter at the left costal arch (<xref ref-type="fig" rid="pntd-0001747-g001">Figure 1</xref>) clinically compatible with Buruli ulcer disease (BUD) at the &#x201C;Centre Hospitalier R&#xE9;gional Maritime&#x201D; (CHR Maritime), Ts&#xE9;vi&#xE9;, in July 2010. His hometown, a village located close to the river &#x201C;Haho&#x201D; in the central district &#x201C;Yoto&#x201D; of the &#x201C;R&#xE9;gion Maritime&#x201D;, constitutes one of the BUD-endemic foci in Togo <xref ref-type="bibr" rid="pntd.0001747-Bretzel1">[1]</xref>. The patient's BCG vaccination status was positive and no other family member was diagnosed with BUD before. The lesion was laboratory confirmed by conventional IS<italic>2404</italic> PCR from a 3-mm punch biopsy sample (<xref ref-type="table" rid="pntd-0001747-t001">Table 1</xref>) at the Department of Infectious Diseases and Tropical Medicine (DITM), Munich, and a full course of rifampicin (300 mg/d) and streptomycin (0.5 g/d) was administered for eight weeks at the peripheral health post (&#x201C;Unit&#xE9; de Soins P&#xE9;riph&#xE9;rique&#x201D;, USP). The patient was fully compliant throughout the entire period of treatment and no complications were reported. In September 2010, the lesion was completely healed under scarification (<xref ref-type="fig" rid="pntd-0001747-g002">Figure 2</xref>) and the patient was considered cured. Weekly follow-up was conducted by the BUD nurse of the village for three months following healing accompanied by monthly follow-up by the BUD nurse of CHR Maritime. No pathological findings were observed until June 2011. In July 2011, the boy (in the meantime nine-year-old) presented again with a secondary nodule (diameter: 30 mm) at the back of the right thigh (<xref ref-type="fig" rid="pntd-0001747-g003">Figure 3</xref>) at CHR Maritime one week after its emergence. The lesion was clinically compatible with BUD and clinical samples were collected and forwarded to the newly established BUD Reference Laboratory at the &#x201C;Institut National d'Hygi&#xE8;ne&#x201D; (INH), Lom&#xE9;, as well as DITM (<xref ref-type="table" rid="pntd-0001747-t001">Table 1</xref>). Microscopy of a Ziehl-Neelsen stained FNA smear was (scanty) positive and the presence of <italic>Mycobacterium ulcerans</italic> DNA was confirmed by IS<italic>2404</italic> real-time qPCR at DITM while conventional IS<italic>2404</italic> PCR remained negative for all samples tested. The secondary lesion ulcerated three weeks after emergence and further samples were collected from the ulcer (diameter: 25&#xD7;30 mm) and forwarded to DITM for analysis. Whereas IS<italic>2404</italic> qPCR reconfirmed the presence of <italic>M. ulcerans</italic> DNA, viability testing of <italic>M. ulcerans</italic> by analysis of mycobacterial ribosomal 16S RNA through a newly established 16S rRNA RT qPCR (specificity: 100%, positivity rate for pre-treatment swab samples: 83.3% [95%-CI: 66.1%&#x2013;100%], limit of detection: six copies of the target sequence) (unpublished data) and culture were negative (<xref ref-type="table" rid="pntd-0001747-t001">Table 1</xref>). Under stringent clinical observation, conventional wound care by daily cleaning with normal saline, disinfection with povidone-iodine, and sterile dressing of the ulcerated lesion was performed at the USP for two weeks. The lesion healed completely (<xref ref-type="fig" rid="pntd-0001747-g004">Figure 4</xref>) five weeks after onset of disease. The patient's parents gave written informed consent for publication.</p>
      <fig id="pntd-0001747-g001" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pntd.0001747.g001</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Primary nodule at the left costal arch, June 2010.</title>
        </caption>
        <graphic xlink:href="pntd.0001747.g001"/>
      </fig>
      <fig id="pntd-0001747-g002" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pntd.0001747.g002</object-id>
        <label>Figure 2</label>
        <caption>
          <title>Scar of the primary nodule at the left costal arch, September 2010.</title>
        </caption>
        <graphic xlink:href="pntd.0001747.g002"/>
      </fig>
      <fig id="pntd-0001747-g003" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pntd.0001747.g003</object-id>
        <label>Figure 3</label>
        <caption>
          <title>Secondary ulcerated nodule at the back of the right thigh, July 2011.</title>
        </caption>
        <graphic xlink:href="pntd.0001747.g003"/>
      </fig>
      <fig id="pntd-0001747-g004" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pntd.0001747.g004</object-id>
        <label>Figure 4</label>
        <caption>
          <title>Scar of secondary nodule at the back of the right thigh, September 2011.</title>
        </caption>
        <graphic xlink:href="pntd.0001747.g004"/>
      </fig>
      <table-wrap id="pntd-0001747-t001" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pntd.0001747.t001</object-id>
        <label>Table 1</label>
        <caption>
          <title>Clinical samples and laboratory results of primary and secondary BUD lesions.</title>
        </caption>
        <alternatives>
          <graphic id="pntd-0001747-t001-1" xlink:href="pntd.0001747.t001"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" rowspan="1" colspan="1">Date of Sample Collection</td>
                <td align="left" rowspan="1" colspan="1">Clinical Presentation and Diameter of Lesion</td>
                <td align="left" rowspan="1" colspan="1">Sample Type</td>
                <td align="left" rowspan="1" colspan="1">Transport Medium</td>
                <td colspan="5" align="left" rowspan="1">Laboratory Results</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">MIC<xref ref-type="table-fn" rid="nt102">a</xref></td>
                <td align="left" rowspan="1" colspan="1">IS<italic>2404</italic> PCR<xref ref-type="table-fn" rid="nt103">b</xref></td>
                <td align="left" rowspan="1" colspan="1">IS<italic>2404</italic> qPCR<xref ref-type="table-fn" rid="nt104">c</xref></td>
                <td align="left" rowspan="1" colspan="1">16S RT qPCR<xref ref-type="table-fn" rid="nt105">d</xref></td>
                <td align="left" rowspan="1" colspan="1">CUL<xref ref-type="table-fn" rid="nt106">e</xref></td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">July 20, 2010</td>
                <td align="left" rowspan="1" colspan="1">Primary nodule, 30 mm</td>
                <td align="left" rowspan="1" colspan="1">FNA<xref ref-type="table-fn" rid="nt107">f</xref>Punch biopsy</td>
                <td align="left" rowspan="1" colspan="1">CLS<xref ref-type="table-fn" rid="nt108">g</xref>CLS</td>
                <td align="left" rowspan="1" colspan="1">negND</td>
                <td align="left" rowspan="1" colspan="1">negpos</td>
                <td align="left" rowspan="1" colspan="1">ND<xref ref-type="table-fn" rid="nt109">h</xref>ND</td>
                <td align="left" rowspan="1" colspan="1">NDND</td>
                <td align="left" rowspan="1" colspan="1">NDND</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">July 13, 2011</td>
                <td align="left" rowspan="1" colspan="1">Secondary nodule, 30 mm</td>
                <td align="left" rowspan="1" colspan="1">FNA(1)FNA(2)</td>
                <td align="left" rowspan="1" colspan="1">CLSPANTA<xref ref-type="table-fn" rid="nt111">j</xref></td>
                <td align="left" rowspan="1" colspan="1">pos (1AFB<xref ref-type="table-fn" rid="nt110">i</xref>)neg</td>
                <td align="left" rowspan="1" colspan="1">negpos</td>
                <td align="left" rowspan="1" colspan="1">posneg</td>
                <td align="left" rowspan="1" colspan="1">NDND</td>
                <td align="left" rowspan="1" colspan="1">NDND</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">July 21, 2011</td>
                <td align="left" rowspan="1" colspan="1">Ulcerated secondary nodule, 25&#xD7;30 mm</td>
                <td align="left" rowspan="1" colspan="1">Punch biopsySwab (1)Swab (2)Swab (3)</td>
                <td align="left" rowspan="1" colspan="1">PANTAPANTAPANTAPANTA</td>
                <td align="left" rowspan="1" colspan="1">negnegNDND</td>
                <td align="left" rowspan="1" colspan="1">NDNDnegneg</td>
                <td align="left" rowspan="1" colspan="1">NDNDpospos</td>
                <td align="left" rowspan="1" colspan="1">NDNDnegneg</td>
                <td align="left" rowspan="1" colspan="1">No growth<xref ref-type="table-fn" rid="nt112">k</xref>No growthNDND</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="nt101">
            <label/>
            <p><xref ref-type="table" rid="pntd-0001747-t001">Table 1</xref> shows samples collected from the primary and secondary lesions in July 2010 and 2011 and the corresponding laboratory results. &#x201C;Neg&#x201D; indicates a negative test result, &#x201C;pos&#x201D; indicates a positive test result.</p>
          </fn>
          <fn id="nt102">
            <label>a</label>
            <p>MIC, microscopic examination of acid fast bacilli (AFB) following Ziehl-Neelsen staining conducted at CHR, DITM, and INH (samples from secondary lesion only).</p>
          </fn>
          <fn id="nt103">
            <label>b</label>
            <p>IS<italic>2404</italic> PCR, conventional, single-step, gel-based IS<italic>2404</italic> polymerase-chain-reaction conducted at DITM.</p>
          </fn>
          <fn id="nt104">
            <label>c</label>
            <p>IS<italic>2404</italic> qPCR, real-time quantitative IS<italic>2404</italic> polymerase-chain-reaction conducted at DITM.</p>
          </fn>
          <fn id="nt105">
            <label>d</label>
            <p>16S RT qPCR, <italic>Mycobacterium ulcerans</italic>&#x2013;specific reverse-transcription real-time quantitative polymerase-chain-reaction targeting the ribosomal 16S RNA of <italic>M. ulcerans</italic> conducted at DITM.</p>
          </fn>
          <fn id="nt106">
            <label>e</label>
            <p>CUL, mycobacterial culture on L&#xF6;wenstein-Jensen medium conducted at IML red, synlab, Asklepios Gauting, Germany.</p>
          </fn>
          <fn id="nt107">
            <label>f</label>
            <p>FNA, fine-needle aspiration.</p>
          </fn>
          <fn id="nt108">
            <label>g</label>
            <p>CLS, Puregene cell lysis solution, Qiagen, Germany.</p>
          </fn>
          <fn id="nt109">
            <label>h</label>
            <p>ND, not done.</p>
          </fn>
          <fn id="nt110">
            <label>i</label>
            <p>AFB, acid fast bacilli.</p>
          </fn>
          <fn id="nt111">
            <label>j</label>
            <p>PANTA, transport medium for viable mycobacteria containing Polymyxin B, Amphotericin, Nalidixic acid, Trimethoprim, and Azlocillin.</p>
          </fn>
          <fn id="nt112">
            <label>k</label>
            <p>No growth, culture result negative, no growth of acid fast bacilli.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec id="s2">
      <title>Case Discussion</title>
      <p>BUD caused by infection with <italic>M. ulcerans</italic> may lead to extensive destruction of the skin, soft tissue, and bone with severe fibrous scarring and formation of contractures if left untreated. Pathogenesis of BUD is mediated by the cytotoxic and immunosuppressive exotoxin mycolactone <xref ref-type="bibr" rid="pntd.0001747-Huygen1">[2]</xref>. During the last decade, significant advances in the treatment of BUD have been made and the introduction of standardized antimycobacterial chemotherapy with rifampicin and streptomycin resulted in recurrence rates below 2% <xref ref-type="bibr" rid="pntd.0001747-World1">[3]</xref>.</p>
      <p>While recurrences after surgical excision alone presumably are attributable to the persistence of mycobacteria in macroscopically healthy tissue bordering surgical excision <xref ref-type="bibr" rid="pntd.0001747-Herbinger1">[4]</xref>, little is known about the pathogenesis and immunological mechanisms of secondary BUD lesions evolving after completion of standardized antimycobacterial treatment <xref ref-type="bibr" rid="pntd.0001747-Ruf1">[5]</xref>.</p>
      <p>Development of new skin lesions during antimycobacterial treatment are currently assumed to be caused by immune-mediated, paradoxical reactions (i.e., deteriorating responses to treatment of an infection after initial improvement) which are likely to be triggered by mycobacterial antigens and immune-stimulators released from killed mycobacteria <xref ref-type="bibr" rid="pntd.0001747-OBrien1">[6]</xref>, <xref ref-type="bibr" rid="pntd.0001747-Kibadi1">[7]</xref>.</p>
      <p>Ruf et al. recently reported two BUD patients from Benin who developed a series of secondary BUD lesions after completion of chemotherapy <xref ref-type="bibr" rid="pntd.0001747-Ruf1">[5]</xref>. These lesions may partly represent secondary infection foci that were already present during treatment and appeared as a consequence of delayed paradoxical reactions. However, in particular, lesions occurring more than one year after completion of treatment may have been associated with new <italic>M. ulcerans</italic> infection or mycobacteria surviving antimycobacterial treatment and may have been resolved by immune responses triggered by successful treatment of primary lesions.</p>
      <p>In accordance with the other cases published so far, in the present case a secondary <italic>M. ulcerans</italic> lesion was laboratory confirmed by microscopic detection of acid fast bacilli and IS<italic>2404</italic> real-time qPCR, whereas cultures remained negative. Furthermore, analysis of mycobacterial ribosomal 16S RNA did not provide evidence for the presence of viable bacilli.</p>
      <p>As shown by Ruf et al. histopathological analysis of surgically excised late-onset secondary lesions revealed characteristical features of BUD as well as massive leukocyte infiltration of necrotic areas characteristic for successfully treated lesions. As there was no surgical intervention for the secondary lesion of the Togolese patient, clinical samples for histopathological analysis were not available.</p>
      <p>Pathogenesis of the secondary BUD lesion in the present case might either be attributable to a second unrecognized focus of killed <italic>M. ulcerans</italic> during antibiotic chemotherapy ten months earlier which became clinically apparent due to a late inflammatory response to residual mycobacterial antigens (i.e., late paradoxical reaction), or to re-inoculation of <italic>M. ulcerans</italic> that was cleared by an elevated immune response primed by the successful initial treatment. However, available laboratory methods did not allow distinguishing between late paradoxical reaction and spontaneous host clearance during a second exposure.</p>
      <p>While mycolactone plays a major role in the pathogenesis of primary BUD lesions, the question whether and to which extent the toxin is involved in the pathogenesis of secondary BUD lesions remains unresolved. Sarfo et al. recently demonstrated the detection of mycolactone in human tissue, suggesting its usefulness as a biomarker for monitoring the clinical response to treatment <xref ref-type="bibr" rid="pntd.0001747-Sarfo1">[8]</xref>. Detection of mycolactone in secondary lesions may support the hypothesis that new infection foci are associated with secondary lesions. However, to our knowledge, data on mycolactone in secondary lesions are still lacking.</p>
      <p>Beside previous anecdotal observations on spontaneous clearance of lesions in clinically suspected BUD cases, Gordon et al. recently reported the first case of spontaneous resolution of a laboratory confirmed BUD ulcer in a patient from Australia <xref ref-type="bibr" rid="pntd.0001747-Gordon1">[9]</xref>. Whereas the secondary lesions of the two BUD patients from Benin were surgically excised, the ulcerated lesion of the Togolese case also healed under conventional wound care.</p>
      <p>In the absence of evidence-based guidelines for reliable identification of late-onset secondary immune-mediated lesions and their clinical management, it may be advisable to consider the possibility of spontaneous healing under stringent clinical observation and regular wound care.</p>
      <boxed-text id="pntd-0001747-box001" position="float" orientation="portrait">
        <sec id="s3a">
          <title>Learning Points</title>
          <list list-type="bullet">
            <list-item>
              <p>Secondary BUD lesions may occur as paradoxical reaction (i.e., deteriorating responses to treatment of an infection after initial improvement) during or shortly after treatment; late-onset secondary lesions may occur up to more than one year after completion of treatment.</p>
            </list-item>
            <list-item>
              <p>Characteristic diagnostic results for secondary BUD lesions are positive microscopy and PCR results without evidence for viable bacilli.</p>
            </list-item>
            <list-item>
              <p>The case of the Togolese patient shows that complete healing of secondary lesions without antibiotic or surgical treatment occurs. Therefore, conventional wound care can be considered as a treatment option if continuous clinical observation is possible.</p>
            </list-item>
          </list>
        </sec>
      </boxed-text>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors thank the medical staff of the paediatric ward and laboratory of CHR Maritime, and Kerstin Helfrich and Carolin Mengele (DITM) for excellent technical assistance.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pntd.0001747-Bretzel1">
        <label>1</label>
        <mixed-citation publication-type="journal"><name><surname>Bretzel</surname><given-names>G</given-names></name>, <name><surname>Huber</surname><given-names>KL</given-names></name>, <name><surname>Kobara</surname><given-names>B</given-names></name>, <name><surname>Beissner</surname><given-names>M</given-names></name>, <name><surname>Piten</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Laboratory confirmation of Buruli ulcer disease in Togo, 2007&#x2013;2010</article-title>. <source>PLoS Negl Trop Dis</source><volume>5</volume><issue>7</issue><fpage>e1228</fpage><comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0001228">10.1371/journal.pntd.0001228</ext-link></comment><pub-id pub-id-type="pmid">21811641</pub-id></mixed-citation>
      </ref>
      <ref id="pntd.0001747-Huygen1">
        <label>2</label>
        <mixed-citation publication-type="journal"><name><surname>Huygen</surname><given-names>K</given-names></name>, <name><surname>Adjei</surname><given-names>O</given-names></name>, <name><surname>Affolabi</surname><given-names>D</given-names></name>, <name><surname>Bretzel</surname><given-names>G</given-names></name>, <name><surname>Demangel</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Buruli ulcer disease: prospects for a vaccine</article-title>. <source>Med Microbiol Immunol</source><volume>198</volume>: <fpage>69</fpage>&#x2013;<lpage>77</lpage><pub-id pub-id-type="pmid">19198877</pub-id></mixed-citation>
      </ref>
      <ref id="pntd.0001747-World1">
        <label>3</label>
        <mixed-citation publication-type="journal">World Health Organization (2008) Buruli ulcer: progress report, 2004&#x2013;2008. Wkly Epidemiol Rec 83: 145&#x2013;156.</mixed-citation>
      </ref>
      <ref id="pntd.0001747-Herbinger1">
        <label>4</label>
        <mixed-citation publication-type="journal"><name><surname>Herbinger</surname><given-names>KH</given-names></name>, <name><surname>Brieske</surname><given-names>D</given-names></name>, <name><surname>Nitschke</surname><given-names>J</given-names></name>, <name><surname>Siegmund</surname><given-names>V</given-names></name>, <name><surname>Thompson</surname><given-names>W</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Excision of pre-ulcerative forms of Buruli ulcer disease: a curative treatment?</article-title><source>Infection</source><volume>37</volume><issue>1</issue><fpage>20</fpage>&#x2013;<lpage>25</lpage><pub-id pub-id-type="pmid">19139811</pub-id></mixed-citation>
      </ref>
      <ref id="pntd.0001747-Ruf1">
        <label>5</label>
        <mixed-citation publication-type="journal"><name><surname>Ruf</surname><given-names>M-T</given-names></name>, <name><surname>Chauty</surname><given-names>A</given-names></name>, <name><surname>Adeye</surname><given-names>A</given-names></name>, <name><surname>Ardant</surname><given-names>M-F</given-names></name>, <name><surname>Koussemou</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?</article-title><source>PLoS Negl Trop Dis</source><volume>5</volume><issue>8</issue><fpage>e1252</fpage><comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0001252">10.1371/journal.pntd.0001252</ext-link></comment><pub-id pub-id-type="pmid">21829740</pub-id></mixed-citation>
      </ref>
      <ref id="pntd.0001747-OBrien1">
        <label>6</label>
        <mixed-citation publication-type="journal"><name><surname>O'Brien</surname><given-names>DP</given-names></name>, <name><surname>Robson</surname><given-names>ME</given-names></name>, <name><surname>Callan</surname><given-names>PP</given-names></name>, <name><surname>McDonald</surname><given-names>AH</given-names></name> (<year>2009</year>) <article-title>&#x201C;Paradoxical&#x201D; immune-mediated reactions to Mycobacterium ulcerans during antibiotic treatment: a result of treatment success, not failure</article-title>. <source>Med J</source><volume>191</volume><issue>10</issue><fpage>564</fpage>&#x2013;<lpage>566</lpage></mixed-citation>
      </ref>
      <ref id="pntd.0001747-Kibadi1">
        <label>7</label>
        <mixed-citation publication-type="journal"><name><surname>Kibadi</surname><given-names>K</given-names></name>, <name><surname>Boelaert</surname><given-names>M</given-names></name>, <name><surname>Fraga</surname><given-names>AG</given-names></name>, <name><surname>Kayinua</surname><given-names>M</given-names></name>, <name><surname>Longatto-Filho</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli ulcer (<italic>Mycobacterium ulcerans</italic> disease)</article-title>. <source>PLoS Negl Trop Dis</source><volume>4</volume><issue>7</issue><fpage>e736</fpage><comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0000736">10.1371/journal.pntd.0000736</ext-link></comment><pub-id pub-id-type="pmid">20625556</pub-id></mixed-citation>
      </ref>
      <ref id="pntd.0001747-Sarfo1">
        <label>8</label>
        <mixed-citation publication-type="journal"><name><surname>Sarfo</surname><given-names>FS</given-names></name>, <name><surname>Phillips</surname><given-names>RO</given-names></name>, <name><surname>Rangers</surname><given-names>B</given-names></name>, <name><surname>Mahrous</surname><given-names>EA</given-names></name>, <name><surname>Lee</surname><given-names>RE</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Detection of mycolactone A/B in <italic>Mycobacterium ulcerans</italic>-infected human tissue</article-title>. <source>PLoS Negl Trop Dis</source><volume>4</volume><issue>1</issue><fpage>e577</fpage><comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0000577">10.1371/journal.pntd.0000577</ext-link></comment><pub-id pub-id-type="pmid">20052267</pub-id></mixed-citation>
      </ref>
      <ref id="pntd.0001747-Gordon1">
        <label>9</label>
        <mixed-citation publication-type="journal"><name><surname>Gordon</surname><given-names>CL</given-names></name>, <name><surname>Buntine</surname><given-names>JA</given-names></name>, <name><surname>Hayman</surname><given-names>JA</given-names></name>, <name><surname>Lavender</surname><given-names>CJ</given-names></name>, <name><surname>Fyfe</surname><given-names>JA</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Spontaneous clearance of <italic>Mycobacterium ulcerans</italic> in a case of Buruli ulcer</article-title>. <source>PLoS Negl Trop Dis</source><volume>5</volume><issue>10</issue><fpage>e1290</fpage><comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0001290">10.1371/journal.pntd.0001290</ext-link></comment><pub-id pub-id-type="pmid">22039555</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
